Source Search Page
physiciansweekly.com
Poor respiratory function is associated with greater incidence of depression
16+ hour, 26+ min ago —...Evidence Rating Level: 1 (Excellent) Click to read the study in BMC...
physiciansweekly.com
mNGS Testing for Pathogen Identification in Infected Hosts Results in High Clinical and Diagnostic Utility...
2+ day ago —...published in the February 2024 issue of Infectious Diseases by Williams... ...In the regression model, a positive test [OR = 10.9; 95% CI, 3.2–... ...44.4] and consultation with the company medical director (OR = 3.6...
physiciansweekly.com
AEGIS-II: Negative Primary Endpoint but Infusions Might Benefit Subgroups of Patients
2+ day ago —...Michael Gibson, MD, MS, enrolled 18,219 participants who had been... ...(ie, MI, stroke, or cardiovascular death) at 90 days.... ...Gibson commented. The agent was well tolerated.... ...Gibson emphasized that this observation is hypothesis-generating...
physiciansweekly.com
GLP1 Receptor Agonists Do Not Up Risk for Complications After Emergency Surgery
2+ day ago —...Dixit, M.D., M.P.H., from Stanford University in California, and... ...research letter published online April 22 in the Journal of the American Medical... ...Insights from the leaders in medical research, trending topics in...
physiciansweekly.com
Safety of TAVI Noninferior to SAVR for Patients With Lower Surgical Risk
2+ day ago —...Moritz Seiffert, MD, presented the results of the primary safety... ...compared with the SAVI group in the DEDICATE trial.... ...ACC 2024 Scientific Session, April 6-8, 2024, Atlanta, GA.... ...The present analysis tested for non-inferiority of TAVI versus SAVR...
physiciansweekly.com
Protein Drinks and Exercise Intervention Improve Physical Performance in Frail Patients Undergoing TAVR...
2+ day ago —...Therefore, Jonathan Afilalo, MD, MSc, and colleagues conducted the... ...PERFORM-TAVR trial (NCT03522454) at 11 hospitals in Canada to explore... ...Afilalo concluded. Afilalo J, et al.... ...Afilalo explained....
physiciansweekly.com
PCSKP Inhibitor Achieves LDL-C Goals for Patients With High Risk for Cardiovascular Disease
2+ day ago —...Lerodalcibep reduced low-density lipoprotein-cholesterol (LDL-C)... ...Up to 90% of participants who took lerodalcibep achieved the dual... ...other oral lipid-lowering agents, was 116 mg/dL”, underlined Eric Klug... ...Presented at: ACC 2024 Scientific Session, April 6-8, 2024, Atlanta, GA...
physiciansweekly.com
Analyzing the Diagnostic Utility of mNGS Testing for Pathogen Detection in Infected Hosts
2+ day ago —...published in the February 2024 issue of Infectious Diseases by Williams... ...In the regression model, a positive test [OR = 10.9; 95% CI, 3.2–... ...44.4] and consultation with the company medical director (OR = 3.6...
physiciansweekly.com
A Systematic Review of Medium Vessel Vasculitis Cases Post COVID-19 Vaccination
2+ day ago —...” published in the March 2024 issue of Infectious Diseases by Sanker...
physiciansweekly.com
Exploring the Immunogenicity and Safety of Messenger RNA–Based CMV Vaccine in Healthy Adults
2+ day ago —...Exploring the Immunogenicity and Safety of Messenger RNA–Based CMV... ...The following is a summary of “Safety and immunogenicity of a messenger... ...Mortality Assessing TyG-i as a Predictor of ACM in Critically Ill...